Although the hazard ratios for all-cause mortality (HR 0.64, 95 %CI 0.36-1.12) and stroke (HR 0.67, 95 %CI 0.31-1.44) also favored SGLT2i prescription, they did not reach statistical significance.
← all excerpts
Sodium Glucose Co-Transporter-2 inhibitors in patients with systemic sclerosis with or without heart failure.
1
—
—